Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema

Chest

Volumn 115, Issue 3, 1999, Pages 697-702

  Fujimoto, Keisaku ^a   Kubo, Keishi ^a   Yamamoto, Hiroshi ^a   Yamaguchi, Shinji ^a   Matsuzawa, Yukinori ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroid; Eosinophil; Eosinophil cationic protein; IL 8; Induced sputum; Neutrophil; Neutrophil elastase; Pulmonary emphysema

Indexed keywords

ALPHA 1 ANTITRYPSIN; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; INTERLEUKIN 8; LEUKOCYTE ELASTASE INHIBITOR; PREDNISOLONE;

AIRWAY OBSTRUCTION; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHILIA; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; LUNG ALVEOLUS; LUNG EMPHYSEMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESIDUAL VOLUME; SPUTUM LEVEL; VITAL CAPACITY;

EID: 0033033894     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.3.697     Document Type: Article

References (26)

1. 1 Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132:417-433
2. 2 Snider GL, Stone PJ, Lucey EC, et al. A polypeptide derived from the medicinal leech prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia. Am Rev Respir Dis 1985; 132:1155-1161
3. 3 Sommerhoff CP, Nadel JA, Basbaum CB, et al. Neutrophil elastase and cathepsin G stimulate secretion from bovine airway gland serous cells. J Clin Invest 1990; 85:682-689
4. 4 Amitani N, Wilson IR, Rutman R, et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol 1991; 4:26-32
5. 5 Janoff A, Sloan B, Weinbaum G, et al. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977; 115:461-478
6. 6 Lacoste JY, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92:537-548
7. 7 Linden M, Rasmussen JB, Piitulainen E, et al. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148:1226-1232
8. 8 Saetta M, Di-Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150:1646-1652
9. 9 Mendella LA, Manfreda J, Warren CP, et al. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med 1982; 96:17-21
10. 10 Mitchell DM, Gildeh P, Rehahn M, et al. Effects of prednisolone in chronic airway limitation. Lancet 1984; 2:193-196
11. 11 Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114:216-223
12. 12 Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997; 155:1529-1534
13. 13 Llewellyn-Jones CG, Harris TAJ, Stockley RA. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Am J Respir Crit Care Med 1996; 153:616-621
14. 14 Stockley RA, Morrison HM, Kramps JA, et al. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment. Thorax 1986; 41:442-447
15. 15 Keatings VM, Jatakanon A, Worsdell YM, et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542-548
16. 16 Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29
17. 17 Maestrelli P, Saetta M, Stefano AD, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995; 152: 1926-1931
18. 18 Fahy JV, Wong H, Liu J, et al. Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am J Respir Crit Care Med 1995; 152:53-58
19. 19 Popov TA, Pizzichini MMM, Pizzichini E, et al. Some technical factors influencing the induction of sputum for cell analysis. Eur Respir J 1995; 8:559-565
20. 20 Riise GC, Ahlstedt S, Larsson S, et al. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50:360-365
21. 21 Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155:449-453
22. 22 Fujimoto K, Kubo K, Matsuzawa Y, et al. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma. Chest 1997; 112:1241-1247
23. 23 Yoshioka A, Betsuyaku T, Nishimura M, et al. Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. Am J Respir Crit Care Med 1995; 152:2127-2132
24. 24 Smith WB, Gamble JR, Clarke-Lewis I, et al. IL-8 induces neutrophil transendothelial migration. Immunology 1991; 72:65-72
25. 25 Keatings VM, Collins PD, Scott DM, et al. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-534
26. 26 Kwon OJ, Au BT, Collins PD, et al. Tumor necrosis factor-induced interleukin-8 expression in cultured human pulmonary epithelial cells: regulation by dexamethasone. Am J Physiol 1994; 11:L398-L405